Cargando…

Whole blood transfusion improves vascular integrity and increases survival in artemether-treated experimental cerebral malaria

Pathological features observed in both human and experimental cerebral malaria (ECM) are endothelial dysfunction and changes in blood components. Blood transfusion has been routinely used in patients with severe malarial anemia and can also benefit comatose and acidotic malaria patients. In the pres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gul, Saba, Ribeiro-Gomes, Flavia L., Moreira, Aline S., Sanches, Guilherme S., Conceição, Fabiana G., Daniel-Ribeiro, Cláudio Tadeu, Ackerman, Hans C., Carvalho, Leonardo J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187502/ https://www.ncbi.nlm.nih.gov/pubmed/34103601 http://dx.doi.org/10.1038/s41598-021-91499-3

Ejemplares similares

Intravenous whole blood transfusion results in faster recovery of vascular integrity and increased survival in experimental cerebral malaria
por: Gul, Saba, et al.
Publicado: (2023)

L-arginine supplementation and thromboxane synthase inhibition increases cerebral blood flow in experimental cerebral malaria
por: Moreira, Aline S., et al.
Publicado: (2019)

Vascular dysfunction as a target for adjuvant therapy in cerebral malaria
por: Carvalho, Leonardo José de Moura, et al.
Publicado: (2014)

Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine
por: Ong, Peng Kai, et al.
Publicado: (2018)

Increased Neutrophil Percentage and Neutrophil–T Cell Ratio Precedes Clinical Onset of Experimental Cerebral Malaria
por: Freire-Antunes, Lucas, et al.
Publicado: (2023)

Artemether for severe malaria
por: Esu, Ekpereonne, et al.
Publicado: (2014)

Artemether for severe malaria
por: Esu, Ekpereonne B, et al.
Publicado: (2019)

Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol
por: Martins, Yuri C, et al.
Publicado: (2010)

Olfactory drug delivery of artemether-curcumin combination for management of cerebral malaria
por: Jain, Kunal, et al.
Publicado: (2012)

Malaria Related Neurocognitive Deficits and Behavioral Alterations
por: Rosa-Gonçalves, Pamela, et al.
Publicado: (2022)

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia
por: Manyando, Christine, et al.
Publicado: (2010)

Long-term effect of uncomplicated Plasmodium berghei ANKA malaria on memory and anxiety-like behaviour in C57BL/6 mice
por: de Sousa, Luciana Pereira, et al.
Publicado: (2018)

Immune system challenge improves recognition memory and reverses malaria-induced cognitive impairment in mice
por: de Sousa, Luciana Pereira, et al.
Publicado: (2021)

Interplay Between the Immune and Nervous Cognitive Systems in Homeostasis and in Malaria
por: de Sousa, Luciana Pereira, et al.
Publicado: (2023)

Dynamics and immunomodulation of cognitive deficits and behavioral changes in non-severe experimental malaria
por: Rosa-Gonçalves, Pamela, et al.
Publicado: (2022)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Clinical Efficacy of Artemether-Lumefantrine in Congolese Children with Acute Uncomplicated Falciparum Malaria in Brazzaville
por: Ndounga, Mathieu, et al.
Publicado: (2012)

The Use of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium vivax Malaria
por: Bassat, Quique
Publicado: (2011)

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
por: Valecha, Neena, et al.
Publicado: (2009)

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis
por: Patrocínio-Jesus, Rita, et al.
Publicado: (2019)

Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique
por: Silva-Pinto, André, et al.
Publicado: (2021)

Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)
por: Tiono, Alfred B, et al.
Publicado: (2015)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
por: Zurovac, Dejan, et al.
Publicado: (2008)

Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
por: Gürkov, Robert, et al.
Publicado: (2008)

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
por: Ogutu, Bernhards, et al.
Publicado: (2010)

Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
por: Mugoyela, V, et al.
Publicado: (2011)

Monitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children
por: Dambe, Rosalia, et al.
Publicado: (2015)

Efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Nepal
por: Ghimire, Prakash, et al.
Publicado: (2018)

Genomic Characterization of Recrudescent Plasmodium malariae after Treatment with Artemether/Lumefantrine
por: Rutledge, Gavin G., et al.
Publicado: (2017)

Modelling the optimal dosing schedule for artemether-lumefantrine chemoprophylaxis against malaria
por: Tarning, Joel, et al.
Publicado: (2022)

4148 Thrombocytopenia and whole blood transfusion in children with severe falciparum malaria
por: Ippolito, Matthew M., et al.
Publicado: (2020)

Prevalence of malaria among febrile patients and assessment of efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Dolisie, Republic of the Congo
por: Pembet Singana, Brice, et al.
Publicado: (2022)

Analytical validation of real-time quantitative PCR assays for optimum diagnosis of vivax malaria
por: Almeida-de-Oliveira, Natália Ketrin, et al.
Publicado: (2019)

Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treatment of Malaria: A Randomized Trial
por: Kamya, Moses R, et al.
Publicado: (2007)

A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
por: Chanda, Pascalina, et al.
Publicado: (2007)

Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria
por: Phu, Nguyen H, et al.
Publicado: (2010)

Possible Clinical Failure of Artemether-Lumefantrine in an Italian Traveler with Uncomplicated Falciparum Malaria.
por: Repetto, Ernestina C., et al.
Publicado: (2011)

Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
por: Staehli Hodel, Eva Maria, et al.
Publicado: (2013)

Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin
por: Ogouyèmi-Hounto, Aurore, et al.
Publicado: (2016)

Hybrid Gold(I) NHC-Artemether Complexes to Target Falciparum Malaria Parasites
por: Ouji, Manel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pm3496ct5058sp3vmngso0h3cf